Ganciclovir CAS 82410-32-0 API BW 759 GCV Antiviral CMV Inhibitor High Quality

Ganciclovir (CAS 82410-32-0) na cikin magungunan antiviral na nucleoside, kasancewar wani nau'in abubuwan guanosine.Ganciclovir wani wakili ne na antiviral na mahaifa wanda aka nuna don gani-ko cututtuka na cytomegalovirus (CMV) a cikin marasa lafiya marasa lafiya.Yana da babban bakan, babban tasiri mai hanawa akan cutar ta herpes kuma shine magani na farko don maganin kamuwa da cutar cytomegalovirus tare da tasiri mai karfi akan cutar hepatitis B da kuma adenovirus.Yana da homologue na acyclovir (ACV) tare da tasirin antiviral yana kama da, amma ya fi karfi fiye da aciclovir, yana da tasirin hanawa na musamman akan cytomegalovirus hade da marasa lafiya na AIDS.Ana amfani da shi na asibiti don kula da lokacin shigarwa da lokacin kulawa akan marasa lafiya marasa lafiya (ciki har da masu cutar AIDS) tare da retinitis na cytomegalovirus na lokaci guda.Hakanan za'a iya amfani dashi don rigakafin cutar cytomegalovirus ga marasa lafiya da ke karɓar dashen gabobin jiki ko marasa lafiya AIDS tare da sakamako mai kyau a cikin gwajin serology na cytomegalovirus.

Ganciclovir (CAS 82410-32-0) mai inganci ne mai inganci, mai ƙarancin guba da mai hana ƙwayar cuta mai girma wanda Kamfanin Syntex (Amurka) ya haɓaka.Ita ce magani na farko da FDA ta Amurka ta amince da ita don maganin kamuwa da cutar cytomegalovirus (CMV).An bai wa Syntex na keɓantaccen haƙƙin samarwa.A cikin watan Yuni 1988, an amince da wannan kwamfutar hannu a karon farko don a jera su a cikin Burtaniya, sannan Faransa, Amurka, Japan, da Jamus ta Yamma, Italiya da Kanada da sauran ƙasashe suka amince da ita.Har zuwa karshen watan Yuni na 1999, an amince da shi a cikin kasashe da yankuna fiye da 70 don rigakafin marasa lafiya na rigakafi da kamuwa da cutar cytomegalovirus na marasa lafiya na dashen gabobin.A cikin 2002, allunan Ganciclovir sun sami amincewar FDA, suna samuwa yanzu.